Reliq Health Technologies
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Reliq Health Technologies generated cash of $0, which is more than the previous year. Cash used in financing activities reached the amount of $0 last year.
Cash Flow
| 2012 | -509.00K | -55.73K | 0 |
|---|---|---|---|
| 2013 | -257.90K | 112.72K | 155.58K |
| 2016 | -1.79M | 297.92K | 1.47M |
| 2018 | -8.15M | -106.5K | 17.57M |
| 2020 | -6.25M | 372.27K | 5.55M |
| 2021 | -7.10M | 23K | 7.29M |
| 2023 | 0 | 0 | 0 |
RHT.V Cash Flow Statement (2013 – 2022)
| 2022 | 2020 | 2019 | 2017 | 2015 | 2013 | 2013 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 132.78K | 12.79K | 345.02K | 487.49K | 464.88K | 11.69K | 576.43K |
Operating activities | |||||||
Net income | 0 | -11.78M | -11.12M | -13.79M | -2.83M | -700.97K | -1.40M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 0 | 125.75K | 445.41K | 0 | 6.16K | 2.18K | 1.48K |
Stock-based compensation expense | 0 | 4.36M | 3.75M | 0 | 405.04K | 0 | 56.30K |
| Deferred income tax benefit | 0 | 4.36M | 3.75M | 0 | 405.04K | 0 | 56.30K |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 0 | -1.13M | -479.44K | 0 | 0 | 0 | 0 |
Inventories | 0 | 547.56K | 968.67K | 0 | -113.46K | 0 | 0 |
Accounts payable | 0 | 817.94K | 288.94K | 0 | 0 | 45.37K | -11.67K |
Cash generated by operating activities | 0 | -7.10M | -6.25M | -8.15M | -1.79M | -257.90K | -509.00K |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | -106.5K | -16.5K | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | -50.20K | 0 | 0 | -625 | -55.73K |
Acquisitions Net | 0 | 0 | 422.47K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 23K | 372.27K | -106.5K | 297.92K | 112.72K | -55.73K |
Financing activities | |||||||
Common Stock Issued | 0 | 3.03M | 5.56M | 15M | 1.5M | 155.58K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -120.57K | -7.79K | 0 | 0 | 0 | 0 |
Cash used in financing activities | 0 | 7.29M | 5.55M | 17.57M | 1.47M | 155.58K | 0 |
Net Change In Cash | 0 | 213.5K | -332.23K | 9.31M | -19.46K | 10.40K | -564.74K |
Cash at end of period | 132.78K | 226.29K | 12.79K | 9.80M | 445.42K | 22.09K | 11.69K |